LeadingBiotech: Boston CEO is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Laurent Audoly, Ph.D.
President & CEO at Kymera Therapeutics

Profile

Laurent Audoly is the Chief Executive Officer of Kymera Therapeutics. Laurent joined Kymera from Pierre Fabre, where he was the Global Head of R&D and a managing partner at the PF fund for innovation. Laurent started his drug development career at Pfizer, where he led multiple discovery efforts in inflammation and immunology contributing to the identification of Xeljanz®. Subsequently, he held various strategic, leadership and operational roles at MedImmune, Merck, and Pieris, building global collaborations and therapeutic pipeline value across oncology, autoimmunity, respiratory, neuropsychiatry, dermatology, cardiovascular and metabolic diseases, contributing to the launch of multiple products currently on the market. He earned his PhD in Pharmacology from Vanderbilt and was an American Heart Association postdoctoral fellow at Duke University. Laurent has authored >70 patents and papers published in top-tier scientific journals including J Exp Med, Nature Immunology, Nature Medicine, Nature Neuroscience, and PNAS. Laurent is a co-author on more than 70 peer-reviewed publications and patents and has served on various NIH study sections. He serves as a board member and advisor for multiple healthcare organizations worldwide to help accelerate the discovery and advancement of novel therapies for patients and their families.

Laurent Audoly, Ph.D.'s Network

Agenda Sessions

  • Early Stage Growth Strategies for Biotech

    , 3:45pm